New and innovative interventions in the management of pemphigus

Alexandra Flamm, J. A. Fairley

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Pemphigus is a rare autoimmune blistering disease usually treated with systemic glucocorticoids with adjuvant immunosuppressants or anti-inflammatories. However significant morbidity and mortality is associated with these treatments. This review discusses conventional therapeutic options, as well as new and emerging therapies that may be safer alternatives to broad-based immunosuppression.

Original languageEnglish (US)
Pages (from-to)211-224
Number of pages14
JournalGiornale Italiano di Dermatologia e Venereologia
Volume146
Issue number3
StatePublished - Jan 1 2011

Fingerprint

Pemphigus
Immunosuppressive Agents
Immunosuppression
Glucocorticoids
Autoimmune Diseases
Anti-Inflammatory Agents
Therapeutics
Morbidity
Mortality

All Science Journal Classification (ASJC) codes

  • Dermatology

Cite this

@article{6134605ea36f410dae8a0f9a23933eb4,
title = "New and innovative interventions in the management of pemphigus",
abstract = "Pemphigus is a rare autoimmune blistering disease usually treated with systemic glucocorticoids with adjuvant immunosuppressants or anti-inflammatories. However significant morbidity and mortality is associated with these treatments. This review discusses conventional therapeutic options, as well as new and emerging therapies that may be safer alternatives to broad-based immunosuppression.",
author = "Alexandra Flamm and Fairley, {J. A.}",
year = "2011",
month = "1",
day = "1",
language = "English (US)",
volume = "146",
pages = "211--224",
journal = "Giornale Italiano di Dermatologia e Venereologia",
issn = "0392-0488",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "3",

}

New and innovative interventions in the management of pemphigus. / Flamm, Alexandra; Fairley, J. A.

In: Giornale Italiano di Dermatologia e Venereologia, Vol. 146, No. 3, 01.01.2011, p. 211-224.

Research output: Contribution to journalArticle

TY - JOUR

T1 - New and innovative interventions in the management of pemphigus

AU - Flamm, Alexandra

AU - Fairley, J. A.

PY - 2011/1/1

Y1 - 2011/1/1

N2 - Pemphigus is a rare autoimmune blistering disease usually treated with systemic glucocorticoids with adjuvant immunosuppressants or anti-inflammatories. However significant morbidity and mortality is associated with these treatments. This review discusses conventional therapeutic options, as well as new and emerging therapies that may be safer alternatives to broad-based immunosuppression.

AB - Pemphigus is a rare autoimmune blistering disease usually treated with systemic glucocorticoids with adjuvant immunosuppressants or anti-inflammatories. However significant morbidity and mortality is associated with these treatments. This review discusses conventional therapeutic options, as well as new and emerging therapies that may be safer alternatives to broad-based immunosuppression.

UR - http://www.scopus.com/inward/record.url?scp=79959656697&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959656697&partnerID=8YFLogxK

M3 - Article

VL - 146

SP - 211

EP - 224

JO - Giornale Italiano di Dermatologia e Venereologia

JF - Giornale Italiano di Dermatologia e Venereologia

SN - 0392-0488

IS - 3

ER -